Stocks & Investing
Stocks and Investing
Stocks and Investing
Fri, September 8, 2023
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
[ Fri, Sep 08th 2023
] - WOPRAI
Jason Gerberry Maintained (TEVA) at Strong Buy with Increased Target to $13 on, Sep 8th, 2023
Jason Gerberry of B of A Securities, Maintained "Teva Pharmaceutical Industries Limited" (TEVA) at Strong Buy with Increased Target from $12 to $13 on, Sep 8th, 2023.
Jason has made no other calls on TEVA in the last 4 months.
There are 3 other peers that have a rating on TEVA. Out of the 3 peers that are also analyzing TEVA, 2 agree with Jason's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Ashwani Verma of "UBS" Upgraded from Strong Sell to Hold and Increased Target to $8 on, Thursday, July 6th, 2023
- Thibault Boutherin of "Morgan Stanley" Initiated at Hold and Held Target at $10 on, Thursday, May 25th, 2023
This is the rating of the analyst that currently disagrees with Jason
- Umer Raffat of "Evercore ISI Group" Upgraded from Hold to Buy on, Thursday, May 18th, 2023
